Insider · CIK 0001292816

Magni Giovanni

Reports to the SEC for 1 company · HERCULES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001292816

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-09-11	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+500 sh	$139.56	+$69.8K	22,561
2020-09-11	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−318 sh	$505.02	−$161K	22,243
2020-09-11	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+500 sh	—	—	22,743
2020-09-11	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−248 sh	$505.02	−$125K	22,495
2020-09-11	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−500 sh	—	—	0
2020-09-11	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−500 sh	—	—	0
2020-09-10	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+400 sh	$160.37	+$64.1K	22,030
2020-09-10	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−263 sh	$503.45	−$132K	21,767
2020-09-10	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+500 sh	$215.98	+$108K	22,267
2020-09-10	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−357 sh	$503.45	−$180K	21,910
2020-09-10	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+500 sh	$326.15	+$163K	22,410
2020-09-10	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−412 sh	$503.45	−$207K	21,998
2020-09-10	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+371 sh	$333.34	+$124K	22,369
2020-09-10	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−308 sh	$503.45	−$155K	22,061
2020-09-10	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−400 sh	—	—	400
2020-09-10	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−500 sh	—	—	1,000
2020-09-10	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−500 sh	—	—	1,500
2020-09-10	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−371 sh	—	—	1,485
2020-09-08	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+400 sh	—	—	21,829
2020-09-08	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−199 sh	$478.82	−$95.3K	21,630
2020-09-08	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−400 sh	—	—	400
2020-09-05	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+500 sh	—	—	21,677
2020-09-05	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−248 sh	$484.23	−$120K	21,429
2020-09-05	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−500 sh	—	—	1,000
2020-09-04	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+500 sh	—	—	21,425
2020-09-04	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−248 sh	$484.23	−$120K	21,177
2020-09-04	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−500 sh	—	—	1,500
2020-09-03	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+371 sh	—	—	21,109
2020-09-03	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−184 sh	$494.24	−$90.9K	20,925
2020-09-03	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−371 sh	—	—	1,485
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+3,500 sh	$84.57	+$296K	15,935
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+3,500 sh	$98.04	+$343K	19,435
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+3,250 sh	$107.32	+$349K	22,685
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+3,200 sh	$117.00	+$374K	25,885
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+3,000 sh	$119.54	+$359K	28,885
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+2,000 sh	$139.56	+$279K	30,885
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+1,200 sh	$160.37	+$192K	32,085
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+1,000 sh	$215.98	+$216K	33,085
2020-08-19	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+500 sh	$326.15	+$163K	33,585
2020-08-19	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, Chief Strategy Officer	SSale	−315 sh	$517.64	−$163K	33,270
2020-08-19	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, Chief Strategy Officer	SSale	−5,392 sh	$518.76	−$2.8M	27,878
2020-08-19	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, Chief Strategy Officer	SSale	−1,133 sh	$519.89	−$589K	26,745
2020-08-19	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, Chief Strategy Officer	SSale	−5,668 sh	$520.94	−$2.95M	21,077
2020-08-19	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, Chief Strategy Officer	SSale	−339 sh	$521.86	−$177K	20,738
2020-08-19	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−3,500 sh	—	—	0
2020-08-19	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−3,500 sh	—	—	0
2020-08-19	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−3,250 sh	—	—	0
2020-08-19	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−3,200 sh	—	—	0
2020-08-19	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−3,000 sh	—	—	0
2020-08-19	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−2,000 sh	—	—	500

Recent filings

Accepted (ET)
Sep 144
Magni Giovanni0001812865-20-000043
SEC(opens sec.gov)
Sep 94
Magni Giovanni0001812865-20-000031
SEC(opens sec.gov)

Companies

BIO-RAD LABORATORIES, INC.EVP, Chief Strategy OfficerBIO

Address

C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE

HERCULES, CA, 94547